Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,077,792
+$3,904,400 QoQ
Shares Held
252,400
+226.1% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.29%
of 13F equity value
Holder Rank
#541
of 2,821 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Dec 31, 2023CallValue
$1,237,970
CallShares
43,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAR1 Capital Management, LLC holds $14,801,650 across 7 Drug Manufacturers - General names. PFE ranks #1 (41.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
252,400 | $6,077,792 | |
| 2 | BIIB |
Biogen Inc.
|
17,900 | $3,867,474 | |
| 3 | SNY |
Sanofi
|
57,100 | $2,435,886 | |
| 4 | NVO |
Novo Nordisk A S
|
27,000 | $1,294,380 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,648 | $587,228 | |
| 6 | MRK |
Merck & Co., Inc.
|
3,140 | $403,490 | |
| 7 | OGN |
Organon & Co.
|
10,000 | $135,400 |
All Filings in PFE
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,077,792 | 252,400 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,173,392 | 77,400 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $1,802,760 | 72,400 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,131,312 | 44,400 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $955,056 | 39,400 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,040,207 | 41,050 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $929,876 | 35,050 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,040,393 | 35,950 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,117,801 | 39,950 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,950,990 | 106,342 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,237,970 | 43,000 | Call | Sole | 2024-02-14 | |
| 2023-12-31 | $500,946 | 17,400 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||